Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors

Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors Guidance documents for management of drugs for clinical trials involving human subjects. The sponsor must ensure that the clinical trial is conducted in accordance with the requirements of the protocol, which has been authorized by Health Canada and approved by REB(s). 2020-04-07 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19 pandemicdrugs for clinical trials involving human subjectsResearch Ethics Board (REB). Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsorsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/management-clinical-trials-during-covid-19-pandemic.html Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsorsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/gestion-essai-clinique-pendant-pandemie-covid-19.html

Guidance documents for management of drugs for clinical trials involving human subjects. The sponsor must ensure that the clinical trial is conducted in accordance with the requirements of the protocol, which has been authorized by Health Canada and approved by REB(s).

Data and Resources

Similar records